Caranx Medical
About Caranx Medical
Caranx Medical is a MedTech company specializing in robotic surgery, founded in 2019 by Truffle Capital. The company’s primary goal is to develop tools that assist surgeons by integrating augmented reality and artificial intelligence technologies. These compact, autonomous robots are designed to perform specific operations under surgeon supervision, leveraging machine learning trained on extensive patient records and video-recorded procedures.
Caranx Medical is actively developing prototype robots for autonomous transcatheter aortic valve replacement or implantation (TAVI), aiming to eliminate the need for major open-heart surgery. They are also working on an autonomous robot for bariatric surgery. The company has licensed “everting growing robots” technology from Stanford University and UC Santa Barbara, which is inspired by the biomechanics of snail’s eyes and could significantly impact medical procedures like navigating the digestive tract and blood vessels, potentially reducing mortality. In July 2025, Caranx Medical’s TAVIPILOT Soft, an AI software for real-time intra-operative guidance of transcatheter heart valve implantation, received FDA clearance for commercialization in the US. The company announced the first clinical use of its TAVIPILOT Soft in October 2025 in France, and the TAVIPILOT robot in December 2025 in Australia.
As of December 2025, Caranx Medical was acquired by Affluent Medical for €16.6 million and will be combined with Artedrone to form a new entity called Carvolix. This new entity aims to be a pioneer in cardiovascular therapies combining innovative implants and AI-driven autonomous mini-robots. Carvolix plans to focus on cardiac valve replacement and brain stroke treatment.
Focus Areas
Business Intelligence
| Technology | AI-driven software (TAVIPILOT Soft), autonomous robotic systems (TAVIPILOT robot), machine learning, augmented reality |
What Physicians Need to Know
Caranx Medical's TAVIPILOT Soft aims to enhance precision and improve patient outcomes in TAVI procedures by providing real-time intra-operative guidance, potentially reducing the learning curve for complex interventions and making them accessible to a broader range of cardiologists. The compatibility with existing cardiac imaging systems and TAVI heart valves ensures seamless integration into current clinical workflows. Physicians can expect improved accuracy in valve positioning and delivery, leading to more predictable and safer valve deployment.
Caranx Medical's TAVIPILOT Soft is designed to be compatible with all cardiac imaging systems and major TAVI heart valves on the market. This broad compatibility facilitates integration into existing interventional cardiology centers without requiring significant changes to current equipment or preferred valve types.
Products by Caranx Medical
What the Web Says
Caranx Medical is a French medical device company specializing in AI-driven software and robotics for Transcatheter Aortic Valve Implantation (TAVI) procedures. Their flagship product, TAVIPILOT Soft, received FDA clearance in July 2025 for real-time intra-operative guidance during TAVI, aiming to enhance precision and improve patient outcomes. The company was acquired by Affluent Medical for EUR 16.6 million on January 30, 2026.
Overall: PositiveStrengths
- AI-driven software enhances precision in TAVI procedures
- Aims to democratize access to TAVI procedures by allowing more cardiologists to perform them
- Potential to significantly increase the number of patients benefiting from TAVI
- FDA clearance for TAVIPILOT Soft marks a significant milestone
- Focus on revolutionizing medicine and saving lives through AI and robotics
Limitations
- No specific product or employer reviews found on G2, Glassdoor, Capterra, or Reddit.
- Limited information available regarding company culture or employee experiences.
- No direct feedback from healthcare IT reviewers was found.
- The company was recently acquired, so long-term independent reviews may be scarce.
Based on reviews from: BioSpace, Medical Device and Diagnostic Industry, Pharmabiz.com, FDA.gov, Google Search, Reddit, G2, Capterra
Last updated: 2026-10-21
Videos
News, demos, and interviews about Caranx Medical.
Videos load interactively. If none appear, search YouTube for Caranx Medical →
Press & Coverage
Frequently Asked Questions
Related Companies
OrthoAI is an innovative AI-powered platform designed to assist orthopedic surgeons in clinical decision-making, surgical planning, and patient care. It functions as a 24/7 surgical companion, providing evidence-based answers to complex clinical questions, surgical techniques, and theoretical queries. The platform leverages a meticulously curated database developed by expert orthopedic surgeons, integrates with PubMed for the […]
NuvoAir is a digital health company that provides a value-based specialty care platform focused on proactive, continuous virtual care for individuals with heart and lung conditions. The company aims to transform the diagnosis and management of chronic cardiopulmonary conditions by integrating advanced monitoring technology, data analytics, and evidence-based interventions delivered by a multidisciplinary team. NuvoAir’s […]
Infinite Biomedical Technologies, LLC (IBT) is a medical device company established in 1997 with roots at Johns Hopkins University. The company is dedicated to developing innovative solutions for individuals with upper limb loss and differences, aiming to transform laboratory research into practical medical devices. IBT focuses on advanced prosthetic control systems and related technologies to […]
The search results indicate that “Strain AI” is not a single, unified company serving physicians and healthcare providers in the traditional medical sense. Instead, the term “Strain AI” appears to be a general descriptor used by several distinct companies operating primarily in the cannabis industry, leveraging AI to recommend cannabis strains based on user preferences, […]
Samsung is a global technology leader that has significantly expanded its presence in the healthcare sector, leveraging its expertise in AI, imaging, and connected devices. The company aims to improve patient care and outcomes by providing advanced diagnostic solutions, personalized health insights, and integrated digital health platforms. Samsung’s healthcare initiatives focus on bridging the gap […]
Philips (Cardiologs) is a healthcare AI company that specializes in transforming cardiac diagnostics through medical-grade artificial intelligence and cloud technology. Their core offering is the Cardiologs Holter platform, which utilizes deep neural networks to analyze continuous ambulatory ECGs. This platform is designed to streamline ECG analysis, reduce reporting errors, and accelerate diagnostic reporting, ultimately empowering […]